Taking the breast cancer journey with someone who's been "in your shoes"
After Breast Cancer Diagnosis (ABCD) was founded in 1999 by Emmy Award—winning journalist Melodie Wilson Oldenburg. Created by women who have experienced breast cancer themselves, ABCD provides free, personalized information and one-to-one support to those affected by breast cancer—patients, their families, and friends. Trained and professionally supported volunteer survivors and co-survivors help those who are battling breast cancer—from the newly diagnosed to those in treatment and beyond. While research continues to search for a cure, ABCD focuses on those who are currently taking the breast cancer journey.
Personalized support is available through ABCD’s:
For support and more information contact 800-977-4121 Monday through Friday 8 AM to 9 PM CST, Saturday 8 AM to 2 PM CST or helpline@abcdmentor.org
Olaparib Plus Chemo May Not Improve Outcomes vs Chemo Alone in BRCA Wild-Type TNBC
April 23rd 2024Patients with BRCA wild-type triple-negative breast cancer treated with olaparib on a gap schedule with chemotherapy did not experience improved responses compared with chemotherapy alone in the neoadjuvant setting.
Nurse Practitioners Weigh in on Data From the San Antonio Breast Cancer Symposium
January 16th 2023Loyda Braithwaite, MSN, RN, AGPCNP-BC, AOCNP; and Jamie Carroll, APRN, CNP, MSN, highlight presentations from the 2022 San Antonio Breast Cancer Symposium that will influence oncology nursing practice.
FDA Grants Accelerated Approval to Fam-Trastuzumab Deruxtecan-Nxki in HER2+ Solid Tumors
April 5th 2024The FDA granted accelerated approval to fam-trastuzumab deruxtecan-nxki (Enhertu) for patients with unresectable or metastatic HER2-positive solid tumors who have received prior systemic treatment.